ClinVar Genomic variation as it relates to human health
NM_014714.4(IFT140):c.634G>A (p.Gly212Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_014714.4(IFT140):c.634G>A (p.Gly212Arg)
Variation ID: 31683 Accession: VCV000031683.33
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 1592176 (GRCh38) [ NCBI UCSC ] 16: 1642177 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 6, 2016 Oct 20, 2024 Sep 1, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_014714.4:c.634G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_055529.2:p.Gly212Arg missense NC_000016.10:g.1592176C>T NC_000016.9:g.1642177C>T NG_032783.1:g.24933G>A - Protein change
- G212R
- Other names
- -
- Canonical SPDI
- NC_000016.10:1592175:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00004
The Genome Aggregation Database (gnomAD) 0.00008
Trans-Omics for Precision Medicine (TOPMed) 0.00008
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00015
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
IFT140 | - | - |
GRCh38 GRCh37 |
1062 | 1915 | |
LOC105371046 | - | - | - | GRCh38 | - | 613 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Aug 27, 2023 | RCV000024363.24 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Sep 1, 2023 | RCV000255441.16 | |
Pathogenic/Likely pathogenic (2) |
no assertion criteria provided
|
Jun 1, 2017 | RCV000515934.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jan 1, 2018 | RCV000626465.2 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Apr 14, 2022 | RCV001249674.6 | |
Pathogenic (1) |
no assertion criteria provided
|
Oct 25, 2018 | RCV001328311.1 | |
IFT140-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Sep 6, 2024 | RCV004752723.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jul 15, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003818299.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Likely pathogenic
(Jan 10, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000915705.1
First in ClinVar: May 27, 2019 Last updated: May 27, 2019 |
Comment:
The IFT140 c.634G>A (p.Gly212Arg) variant has been reported in two studies and was found in four probands, including one sibling-pair, one in a homozygous state … (more)
The IFT140 c.634G>A (p.Gly212Arg) variant has been reported in two studies and was found in four probands, including one sibling-pair, one in a homozygous state and three in a compound heterozygous state (Perrault et al. 2012; Helm et al. 2017). One of these probands, who carried the splice-site mutation on the other allele, was clinically diagnosed with Jeune syndrome. Jeune syndrome has overlapping symptoms with Mainzer-Saldino syndrome with the additional phenotype of asphyxiating thoracic dystrophy. The p.Gly212Arg variant is reported at a frequency of 0.000095 in the European (non-Finnish) population of the Genome Aggregation Database. In vitro studies of the p.Gly212Arg variant in retinal pigment epithelial cells showed changes to the cellular localization of the variant protein (Perrault et al. 2012). In vitro analysis in lymphocyte cells found that the p.Gly212Arg variant affected splicing of exon 6 (Helm et al. 2017). Based on the evidence, the p.Gly212Arg variant is classified as likely pathogenic for Mainzer-Saldino syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. (less)
|
|
Pathogenic
(Jan 31, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Retinitis pigmentosa 80
Affected status: yes
Allele origin:
germline
|
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Accession: SCV001423625.1
First in ClinVar: Jul 25, 2020 Last updated: Jul 25, 2020 |
Comment:
[ACMG/AMP: PVS1, PS3, PM2, PM3, PP3, PP5] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], … (more)
[ACMG/AMP: PVS1, PS3, PM2, PM3, PP3, PP5] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is supported by well-established in vitro or in vivo functional studies to have a damaging effect on protein function or splicing [PS3], is absent from or rarely observed in large-scale population databases [PM2], is detected in trans with a known pathogenic variant [PM3], is predicted to be damaging by multiple functional prediction tools [PP3], was reported as a pathogenic/likely pathogenic alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory) [PP5]. (less)
|
|
Pathogenic
(Apr 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000322476.8
First in ClinVar: Oct 09, 2016 Last updated: Mar 04, 2023 |
Comment:
Published functional studies demonstrate a damaging effect (Perrault et al., 2012; Helm et al., 2017); Variant impacting the last nucleotide of an exon in a … (more)
Published functional studies demonstrate a damaging effect (Perrault et al., 2012; Helm et al., 2017); Variant impacting the last nucleotide of an exon in a gene for which loss-of-function is a known mechanism of disease, and splice predictors support a deleterious effect; This variant is associated with the following publications: (PMID: 30924848, 29068549, 30773290, 28724397, 29688594, 28559085, 32371413, 28288023, 22503633, 31589614) (less)
|
|
Pathogenic
(Aug 27, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000640305.6
First in ClinVar: Dec 26, 2017 Last updated: Feb 20, 2024 |
Comment:
This variant is present in population databases (rs201188361, gnomAD 0.009%). For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus … (more)
This variant is present in population databases (rs201188361, gnomAD 0.009%). For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this missense change affects IFT140 function (PMID: 22503633, 28724397). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 31683). This missense change has been observed in individual(s) with Mainzer-Saldino syndrome, Jeune synrome, or Senior-Loken syndrome (PMID: 22503633, 28559085, 28724397). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 212 of the IFT140 protein (p.Gly212Arg). This variant also falls at the last nucleotide of exon 6, which is part of the consensus splice site for this exon. (less)
|
|
Pathogenic
(Jan 01, 2018)
|
criteria provided, single submitter
Method: research
|
Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Laboratory of Medical Genetics (UMR_S 1112), INSERM/Strasbourg University
Accession: SCV000746987.1
First in ClinVar: Dec 26, 2017 Last updated: Dec 26, 2017 |
Number of individuals with the variant: 1
Family history: yes
Sex: female
Ethnicity/Population group: Caucasian
|
|
Pathogenic
(Jan 01, 2018)
|
criteria provided, single submitter
Method: research
|
Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Laboratory of Medical Genetics (UMR_S 1112), INSERM/Strasbourg University
Accession: SCV000746992.1
First in ClinVar: May 06, 2018 Last updated: May 06, 2018 |
Number of individuals with the variant: 1
Family history: yes
Sex: female
|
|
Pathogenic
(Apr 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Retinitis pigmentosa 80
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002809847.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Sep 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004133725.10
First in ClinVar: Nov 20, 2023 Last updated: Oct 20, 2024 |
Comment:
IFT140: PM3:Very Strong, PM2, PP3
Number of individuals with the variant: 1
|
|
Pathogenic
(May 04, 2012)
|
no assertion criteria provided
Method: literature only
|
SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000045656.9
First in ClinVar: Apr 04, 2013 Last updated: Mar 10, 2024 |
Comment on evidence:
In 2 affected members of a family with short-rib thoracic dysplasia-9 without polydactyly (SRTD9; 266920), who had a clinical diagnosis of Mainzer-Saldino syndrome, Perrault et … (more)
In 2 affected members of a family with short-rib thoracic dysplasia-9 without polydactyly (SRTD9; 266920), who had a clinical diagnosis of Mainzer-Saldino syndrome, Perrault et al. (2012) identified compound heterozygosity for 2 mutations in the IFT140 gene: a c.634G-A transition resulting in a gly212-to-arg (G212R) substitution, and a 1-bp duplication (c.3916dup; 614620.0006), resulting in a frameshift and premature termination (Ala1306GlyfsTer56). Neither mutation was found in 200 control chromosomes and both were predicted to be deleterious. In vitro functional expression studies in retinal pigment epithelial cells demonstrated that the G212R mutant protein had partial to complete loss of basal body localization and an increase of cytoplasmic staining. The patients had early-onset retinitis pigmentosa with poor visual acuity, chronic renal failure leading to end-stage renal disease, and cholestasis. The kidneys were hyperechogenic with loss of corticomedullary differentiation. Both also had skeletal anomalies, including short stature, craniosynostosis, and phalangeal cone-shaped epiphyses. Psychomotor development was normal at ages 4 and 10 years, respectively. Perrault et al. (2012) also identified compound heterozygosity for the G212R mutation and a splice site mutation in the IFT140 gene (614620.0002) in an 18-month-old boy with a clinical diagnosis of Jeune syndrome, who exhibited short thorax with short ribs and trident-shaped spurs on long bones. In a 6.5-year-old British boy with short stature, short ribs and narrow thorax, retinal dystrophy, and end-stage renal failure, who also exhibited brachydactyly and ectodermal features and received a clinical diagnosis of Sensenbrenner syndrome (see 218330), Bayat et al. (2017) identified compound heterozygosity for the G212R mutation and a c.2278C-T transition in the IFT140 gene, resulting in an arg760-to-ter (R760X; 614620.0016) substitution. His unaffected parents were each heterozygous for 1 of the mutations. In a 10-year-old boy with features of Mainzer-Saldino syndrome, who exhibited retinal dystrophy, acute-onset renal failure, and skeletal anomalies including bilateral coxa vara, broad femoral necks with mild bowing of the femoral diaphyses, and brachydactyly with shortened metacarpals and cone-shaped phalangeal epiphyses, Helm et al. (2017) identified homozygosity for the c.634G-A transition (c.634G-A, NM_014714.3) at the exon 6 donor splice site of the IFT140 gene, resulting in the G212R substitution at a conserved residue within the WD40 domain. His unaffected mother was heterozygous for the variant, but his father did not carry the mutation. Analysis of exome data indicated that the proband had chromosome 16 maternal heteroisodisomy, with segmental isodisomy at 16p13, suggesting that an early error in meiosis occurred in the maternal gamete. Helm et al. (2017) identified 2 different-sized PCR products from patient cells, the smaller of which was missing exon 6, resulting in frameshift and premature termination at residue 171. Functional analysis in ift140-morphant zebrafish demonstrated some improvement of gastrulation defects with the G212R mutant, but rescue was not as significant as that with wildtype IFT140, suggesting that G212R represents a partial loss-of-function variant. (less)
|
|
Pathogenic
(Jun 01, 2017)
|
no assertion criteria provided
Method: research
|
Asphyxiating thoracic dystrophy
Affected status: yes
Allele origin:
maternal
|
Dan Cohn Lab, University Of California Los Angeles
Accession: SCV000612040.1
First in ClinVar: Dec 10, 2017 Last updated: Dec 10, 2017 |
|
|
Pathogenic
(Sep 06, 2024)
|
no assertion criteria provided
Method: clinical testing
|
IFT140-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005363836.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The IFT140 c.634G>A variant is predicted to result in the amino acid substitution p.Gly212Arg. This variant has been reported in multiple individuals with IFT140-related ciliopathy … (more)
The IFT140 c.634G>A variant is predicted to result in the amino acid substitution p.Gly212Arg. This variant has been reported in multiple individuals with IFT140-related ciliopathy (for examples, see Perrault et al. 2012. PubMed ID: 22503633; Bayat. 2017. PubMed ID: 28288023). With a second pathogenic variant on the opposite chromosome (in trans), the variant was documented to be causative for Mainzer-Saldino Syndrome and Jeune Syndrome in an adult patient and a child patient, respectively (Perrault et al. 2012. PubMed: 22503633). It has also been found in the compound heterozygous state in an individual with cleft palate (Wilson et al. 2023. PubMed ID: 37010288). This variant has been shown to disrupt splicing in an in vivo model, leading to loss of function (Helm et al. 2017. PubMed ID: 28724397). This variant is reported in 0.0093% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. (less)
|
|
Pathogenic
(Oct 25, 2018)
|
no assertion criteria provided
Method: clinical testing
|
Nephronophthisis
Affected status: yes
Allele origin:
unknown
|
Sydney Genome Diagnostics, Children's Hospital Westmead
Accession: SCV001449335.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This patient is heterozygous for a c.634G>A (p.Gly212Arg) in the IFT140 gene. This variant has been previously reported in conjunction with a second pathogenic IFT140 … (more)
This patient is heterozygous for a c.634G>A (p.Gly212Arg) in the IFT140 gene. This variant has been previously reported in conjunction with a second pathogenic IFT140 mutation in patients with Mainzer-Saldino syndrome (MSS) and Jeune syndrome .Functional studies have shown that this variant affects IFT140 cell localization and therefore this variant is considered to be pathogenic (Perrault et al. 2012, Am. J. Hum.Genet 90, 864-870). (less)
Number of individuals with the variant: 1
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: research
|
asphyxiating thoracic dystrophy
Affected status: yes
Allele origin:
inherited
|
University of Washington Center for Mendelian Genomics, University of Washington
Accession: SCV001479393.1
First in ClinVar: Feb 20, 2021 Last updated: Feb 20, 2021 |
|
|
Pathogenic
(Feb 14, 2019)
|
no assertion criteria provided
Method: literature only
|
Saldino-Mainzer syndrome
Affected status: yes
Allele origin:
germline
|
Yale Center for Mendelian Genomics, Yale University
Study: Yale Center for Mendelian Genomics
Accession: SCV002106584.1 First in ClinVar: Mar 23, 2022 Last updated: Mar 23, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Monogenic causes of chronic kidney disease in adults. | Connaughton DM | Kidney international | 2019 | PMID: 30773290 |
Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. | Zhang W | Human mutation | 2018 | PMID: 29068549 |
Partial uniparental isodisomy of chromosome 16 unmasks a deleterious biallelic mutation in IFT140 that causes Mainzer-Saldino syndrome. | Helm BM | Human genomics | 2017 | PMID: 28724397 |
Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease. | Stone EM | Ophthalmology | 2017 | PMID: 28559085 |
The evolving craniofacial phenotype of a patient with Sensenbrenner syndrome caused by IFT140 compound heterozygous mutations. | Bayat A | Clinical dysmorphology | 2017 | PMID: 28288023 |
Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. | Perrault I | American journal of human genetics | 2012 | PMID: 22503633 |
Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. | Buratti E | Nucleic acids research | 2007 | PMID: 17576681 |
Statistical features of human exons and their flanking regions. | Zhang MQ | Human molecular genetics | 1998 | PMID: 9536098 |
Text-mined citations for rs201188361 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.